Transcode Therapeutics Inc Share Price

NASDAQ: RNAZ

Small Cap

$11.28

-0.08

(-0.68%)

Live

as on September 18, 2025 at 10:39 pm IST

$₹

Transcode Therapeutics Inc Stock Performance

as on September 18, 2025 at 10:39 pm IST

Day's Low
Day's High
$11.15
Day's Price Range
$11.8
$11.28
1.15%
Downside
4.61%
Upside
52 Week's Low
52 Week's High
$6.15
52-Week Price Range
$739.2
$11.28
45.50%
Downside
6453.19%
Upside

Transcode Therapeutics Inc share price movements today

Previous Close: $11.36
Open: $11.68
Volume: 59.7K
Day's Low - High: $11.15 - $11.8
52 Week Low - High: $6.15 - $739.2

Transcode Therapeutics Inc Historical Returns

1 Month Return: + 8.19 %
3 Month Return: + 62.75 %
1 Year Return: -96.49 %
3 Year Return: -100 %
5 Year Return: 0 %

Transcode Therapeutics Inc Stock Fundamentals & Key Indicators

Check Transcode Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.7M

EPS (TTM)

0

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-14.6M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

43063200.00%

Transcode Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Transcode Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Transcode Therapeutics Inc	BUY	$9.7M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	241.54%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$99.3B	45.88%	27.56	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$60.9B	5.45%	14.49	31.37%

Stock Returns calculator for Transcode Therapeutics Inc Stock including INR - Dollar returns

The Transcode Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

1Y
3Y

Transcode Therapeutics Inc investment value today

Current value as on today

₹8,441

Returns

₹91,559

(-91.56%)

Returns from Transcode Therapeutics Inc Stock

₹96,512 (-96.51%)

Dollar Returns*

₹4,953 (+4.95%)

Analyst Recommendation on Transcode Therapeutics Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Transcode Therapeutics Inc. Average target price of $10

Transcode Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Transcode Therapeutics Inc.

What analysts predicted

-12.8%DOWNSIDE

Target Price

$10

Current Price

$11.28

Analyzed by

7 Analysts

Target

$10.00

Transcode Therapeutics Inc target price $10, a slight downside of -12.8% compared to current price of $11.28. According to 7 analysts rating.

Transcode Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Transcode Therapeutics Inc Stock has decreased by -37% in the last 30 days, reflecting a downward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:-37% versus previous 30 day period

Transcode Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	0	-	-	-	-	-
Gross Profit	0	0	0	-	0	0	0	0	0	0
Operating Income	-4	-5	-5	-4	-3	-5	-2	-2	-3	-4
EBITDA	-4	-4	-5	-	-3	-5	-2	0	-12	-4
Interest Expense	0	0	0	-	0	0	0	0	0	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-4	-4	-5	-4	-3	-5	-2	-2	-12	-4
Income Tax Expense	0	0	0	-	0	0	0	0	-	-
Net Income	-4	-4	-5	-4	-3	-5	-2	-2	-12	-4
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	-441.72%	0.00%	0.00%	0.00%	0.00%	0.00%

Transcode Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	-
Gross Profit	-	-	0	0	0	-
Operating Income	0	0	-6	-18	-19	-15
EBITDA	0	0	-6	-17	-17	-16
Interest Expense	0	0	0	17	0	0
Depreciation	-	-	0	0	0	0
Income Before Tax	0	-2	-6	-17	-18	-16
Income Tax Expense	0	0	0	17	0	-16,785
Net Income	0	-2	-6	-35	-18	-16
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Transcode Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-4	-5	-4	-3	-5	-2	-5	-12	-16,349
Operating Cash Flow	-4	-3	-5	-3	-2	-3	-3	-3	-7,287
Investing Cash Flow	0	0	-	0	0	0	-	0	-
Financing Cash Flow	6	7	0	6	0	2	7	8	8,845
Change in Cash	1	3	-4	2	-1	-1	3	5	7,363

Transcode Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-2	-6	-17	-18	-16
Operating Cash Flow	0	-5	-15	-18	-13
Investing Cash Flow	0	0	0	0	0
Financing Cash Flow	1	25	0	15	16
Change in Cash	0	19	-15	-2	3

Global Institutional Holdings in Transcode Therapeutics Inc

Funds	Holdings
Anson Funds Management LP	6.26%
UBS Group AG	1.13%
Sabby Management LLC	0.98%
Warberg Asset Management LLC	0.21%
Corsair Capital Management LLC	0.17%

See all

Insights on Transcode Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 3 months, RNAZ stock has moved up by 62.8%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 211.5%
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 164.9%

About Transcode Therapeutics Inc

transcode therapeutics is a boston based pre-clinical biopharmaceutical company focused on discovery, development and commercialization of a pipeline of innovative microrna (mirnas or mirs) therapeutics for treating metastatic disease.

Organisation	Transcode Therapeutics Inc
Headquarters	6 Liberty Square, Boston, MA, United States, 02109
CEO	Mr. Thomas A. Fitzgerald M.B.A.
E-voting on shares	Click here to vote

Key Management of Transcode Therapeutics Inc

Name	Title
Ms. Susan Duggan M.B.A., R.N.	Senior Vice President of Operations
Dr. Daniel R. Vlock M.D.	Chief Medical Officer
Dr. Philippe P. Calais Ph.D., Pharm., Pharm.D.	Executive Chairman of the Board
Mr. Thomas A. Fitzgerald M.B.A.	Interim CEO, CFO, President, VP of Administration & Director
Dr. Zdravka Medarova Ph.D.	Co-Founder & Chief Scientific Officer
Dr. Anna Moore Ph.D.	Co-Founder, Scientific Advisor & Member of Scientific Advisory Board

FAQs

What is Transcode Therapeutics Inc share price today?

Transcode Therapeutics Inc share price today is $11.28 as on September 18, 2025 at 10:39 pm IST. Transcode Therapeutics Inc share today touched a day high of $11.8 and a low of $11.15.

What is the 52 week high and 52 week low for Transcode Therapeutics Inc share?

Transcode Therapeutics Inc share touched a 52 week high of $739.2 on October 11, 2024 and a 52 week low of $6.15 on April 17, 2025. Transcode Therapeutics Inc stock price today i.e. September 18, 2025 at 10:39 pm IST is trending at $11.28,which is 98.47% down from its 52 week high and 83.48% up from its 52 week low.

What is Transcode Therapeutics Inc's market capitalisation today?

Transcode Therapeutics Inc market capitalisation is $0.00T as on September 18, 2025 at 10:39 pm IST.

How to invest in Transcode Therapeutics Inc Stock (RNAZ) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Transcode Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Transcode Therapeutics Inc Shares that will get you 0.1330 shares as per Transcode Therapeutics Inc share price of $11.28 per share as on September 18, 2025 at 10:39 pm IST.

What is the minimum amount required to buy Transcode Therapeutics Inc Stock (RNAZ) from India?

Indian investors can start investing in Transcode Therapeutics Inc (RNAZ) shares with as little as ₹88.114 or $1 (as of September 18, 2025 at 10:40 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Transcode Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 10:40 pm IST). Based on Transcode Therapeutics Inc share’s latest price of $11.28 as on September 18, 2025 at 10:39 pm IST, you will get 0.8865 shares of Transcode Therapeutics Inc. Learn more about fractional shares .